Herbert L DuPont
Index: Expert Opin. Pharmacother. 12(2) , 293-302, (2011)
Full Text: HTML
Rifaximin is increasingly being used to treat acute and chronic gastrointestinal infections and disorders. The drug exerts its beneficial effect through a variety of gut-selective mechanisms involving the host intestinal microbiota.Abstracts of all publications listed in PubMed on the topic of rifaximin are reviewed to determine their potential value in the understanding of mechanisms of rifaximin activity. The author's extensive file on the drug is also used in the review.Rifaximin inhibits a broad spectrum of bacteria in the bile-rich small bowel and susceptible bacteria in the aqueous colon, and alters microbial virulence and epithelial cell function. The different mechanisms of action of rifaximin potentially explain the use of the drug in widely varied diseases and syndromes.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Rifaximin
CAS:80621-81-4 |
C43H51N3O11 |
Methane biogenesis during sodium azide-induced chemical hypo...
2013-01-15 [Am. J. Physiol. Cell Physiol. 304(2) , C207-14, (2013)] |
Effectiveness of different therapeutic strategies in prevent...
2013-02-01 [Eur. Rev. Med. Pharmacol. Sci. 17(3) , 342-8, (2013)] |
Combination therapy for the treatment and prevention of hepa...
2012-11-01 [Ann. Pharmacother. 46(11) , 1559-63, (2012)] |
Antiprotozoal Activity Profiling of Approved Drugs: A Starti...
2015-01-01 [PLoS ONE 10 , e0135556, (2015)] |
The effect of rifaximin on gut flora and Staphylococcus resi...
2013-06-01 [Dig. Dis. Sci. 58(6) , 1676-82, (2013)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved